JPM: Aridis CEO Truong on why the pandemic hasn't bolstered antibiotics R&D and what needs to change
The COVID-19 pandemic has spurred enormous interest and innovation in vaccines, antivirals and anti-infective drugs and for obvious reasons. There’s another area that might have been buoyed by the ...
ORLANDO, FL / ACCESSWIRE / June 30, 2022 / RedChip Companies will air a new C-Level interview with Aridis Pharmaceuticals (NASDAQ:ARDS) on The RedChip Money Report® on Bloomberg TV, this Saturday, ...
Being one of the two young scientists nominated for the Ta Quang Buu Award in 2018, at the age of 34, Truong Vu Thanh of HCMC University of Science & Technology has made remarkable achievements with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results